| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |